SECURE will increase access to a portfolio of quality-assured antibiotics in a sustainable, equitable and appropriate way. The antibiotic portfolio will be adapted to national public health and clinical needs and will include both existing antibiotics and new antibiotics, where access has been limited because of affordability, recurrent shortages or other market challenges.

GARDP would like to better understand the Cost of Goods Sold (COGs) to support GARDP’s plans for access, manufacturer selection, market shaping, and product optimization, especially for its product range. Additionally, GARDP is interested if there are potential process improvements across input raw material costs, yields, processing times, and facility parameters.

If you are interested to receive complete documentation of this RFP, please send a request to: RFP_Procurement@gardp.org.

Closing date: October 20th 2023